Dopamine receptors, controlling dopamine levels in rat adrenal glands ? comparison with central dopaminergic autoreceptors
- 1 October 1991
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 84 (3) , 195-209
- https://doi.org/10.1007/bf01244970
Abstract
Previous work in this laboratory, as well as observations reported in the literature, indicate that the adrenal medulla contains dopamine (DA) receptors of the D-2 subtype, which among other things are capable of controlling the DA level in rat adrenal glands. To further characterize the DA receptors involved in the control of the adrenal DA level, the effects of 9 DA receptor agonists with various intrinsic activities were compared. After various periods of drug administration the rats were killed by decapitation and the DA content of the adrenal glands and the DOPAC content of the forebrain were measured by high-performance liquid chromatography with electrochemical detection. All the investigated DA receptors agonists caused an increase in adrenal DA level, although statistical significance was not reached in one case /(−)-HW165/. Domperidone, a DA D-2 receptor antagonist which does not readily cross the blood brain barrier, blocked the DA-elevating effects of apomorphine, quinpirole, B-HT 920 and both enantiomers of 3-PPP. For the two ergolines terguride and SDZ 208-920 the blockade by domperidone was not complete, suggesting that their effects are mediated not only through DA, but also through other receptor systems. The dose of domperidone used (3 mg/kg) had but a marginal influence on brain DOPAC levels, supporting the almost exclusively peripheral effect of this agent. Our data indicate that the DA D-2 receptors which control the DA level in the adrenal medulla in rats, have characteristics similar to, though not identical with the autoreceptors in the forebrain.Keywords
This publication has 16 references indexed in Scilit:
- B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal glandEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393Psychopharmacology, 1987
- Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptorsActa Physiologica Scandinavica, 1987
- Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerationsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: Discrepancies between and observationsLife Sciences, 1985
- Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Transdihydrolisuride, a partial dopamine receptor antagonist: Effects on monoamine metabolismEuropean Journal of Pharmacology, 1984
- Effects of B‐HT 920 and B‐HT 933 on Dopamine and Noradrenaline Autoreceptors in the Rat BrainActa Pharmacologica et Toxicologica, 1983
- Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activityBiochemical Pharmacology, 1979